Back to Type 2 Diabetes
NCT07252609
NCT07252609
Who may be able to join
Who might be able to join this trial:
- You are a man or woman who is overweight or obese, with a Body Mass Index (BMI) between 25.0 and 39.9 (this is a number calculated from your height and weight)
- You may or may not have type 2 diabetes
- You are between 30 and 70 years old
- Your HbA1c (a blood test that shows your average blood sugar level over the past few months) is 7.5% or below
Who may not be able to join:
- You have had a heart attack or stroke in the last 6 months
- You have kidney problems or liver problems above a certain level, as shown by specific blood test results (confirm with trial site)
- You have anemia, meaning your hemoglobin (a measure of red blood cells) is below a certain level (confirm with trial site)
- You currently use insulin or any diabetes medication other than metformin
- You have taken antibiotics, probiotics, or prebiotic supplements in the past 3 months
- You regularly do intense physical exercise as part of your normal routine
- You are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
Federico II University
Registry
clinicaltrials_gov
Start date
13 November 2024
Est. completion
8 August 2025
Where this trial is recruiting
🇮🇹 Italy
Primary endpoints
Reduction in Body Weight After 12 Weeks of Oral Sodium Butyrate Supplementation Compared With Placebo
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.